DeCure's autonomous Rare AI scientist is researching a drug-repurposing hypothesis for spontaneous abortion — screening already-approved drugs against its 40-gene Open Targets disease module to publish open-access research. Research is fast; the path to publication is funded in milestone stages.
Disease moduleSpontaneous abortion maps to a 40-gene Open Targets module — the target space DeCure's AI scientist screens approved drugs against.
DeCure.ai methodSignature reversal (LINCS) plus network proximity (STRING) rank already-approved drugs likely to perturb this module — the same engine that produces DeCure.ai's repurposing hypotheses.
Repurposing thesisScreening approved medicines against this disease module, then publishing the evidence for the strongest candidate. Known pharmacology and human exposure data make the first question sharper — they do not establish safety or efficacy in a new indication.
Research record
01
ResearchComing soon
Candidate research + dossier — target rationale, drug-repurposing thesis and evidence pack.proof: Published dossier + on-chain hash
02
ValidationComing soon
In-vitro biological validation at a contract research org (CRO).proof: CRO contract + in-vitro report
03
Peer review & paperComing soon
Peer-reviewed paper published open-access (preprint + journal).proof: DOI + open-access link + on-chain hash
Current lead
No approved-drug candidate for spontaneous abortion is corroborated in the literature DeepSearch retrieved. Some conditions are managed with non-pharmacological care — a device, surgery or physical therapy — rather than a medicine; that may be the case here, or the literature we found may simply be too sparse yet to support a drug-repurposing angle.
Molecular view
phospholipase C epsilon 1 (PLCE1) — PLCE1 is one of the genes genetically linked to this disease in Open Targets — shown as context, not as a drug target we're pursuing: no approved-drug candidate for this disease is yet corroborated in the literature we found.
Loading structure…
helix sheet gtpdrag to rotate · scroll to zoom
RCSB Protein Data Bank · entry 2C5L · 1.9 Å · ligand GUANOSINE-5'-TRIPHOSPHATE (GTP). Experimental structure, not a prediction.
Evidence
Retrieved by DeepSearch across 234,678,978 indexed works and resolved on OpenAlex — ranked by citations, including the results that did not work.
BMJ · 1987 · 26 citations · open access
Prognosis of subsequent pregnancies after recurrent spontaneous abortion in first trimester.
AbstractThe outcome of subsequent pregnancies was studied in 24 women with a history of three or more consecutive spontaneous abortions in the first trimester. Twenty one of the women agreed to forgo active treatment during the study period and three received progestogens or surgical intervention. As the outcome of their first pregnancy after recurrent abortion 18 of the 24 women delivered a liveborn infant after 28 weeks or more. Of all 49 pregnancies in the untreated group during the study, 10 ended in abortion. Only one woman in the study failed to achieve a live birth. Except in exceptional cases encouraging women with recurrent abortion to keep trying for a successful outcome is just as effective as currently recommended treatments.
A multi-omic analysis to investigate the causal associations between circulating proteins and risk of spontaneous abortion and their potential implications
AbstractOBJECTIVE: Spontaneous abortion is a complex disorder with a significant genetic component. Identifying genetic variants influencing spontaneous abortion risk could unveil biological pathways and potential therapeutic targets. METHODS: We performed Mendelian randomization using cis- and trans-protein quantitative trait loci (pQTLs) as instrumental variables to assess causal effects of circulating proteins on spontaneous abortion. Proteins exhibiting differential expression between sexes were excluded. KEGG pathway enrichment was employed to investigate the pathways affected by susceptibility genes, while single-cell transcriptomic analysis was utilized to explore the susceptible cell types with elevated expression of these genes within the uterine endometrium. RESULTS: MMP9 and DC-SIGN were associated with increased spontaneous abortion risk (OR=1.11(1.03-1.19), P=3.70x10-3; OR=1.09(1.02-1.16), p=9.89x10-3), while HBAZ and NELL1 had protective effects (OR=0.96(0.94-0.99), p=5.20x10-3; OR=0.94(0.9-0.98), p=8.54x10-3). Additionally, TMM85 conferred higher spontaneous abortion risk (OR=1.06(1.02-1.1), p=4.72x10-3). Pathway analysis highlighted sphingolipid binding, chemorepellent activity, and tumor necrosis factor receptor activity. Single-cell transcriptomics revealed that MUL1, EMC4, NDC80, and SELL genes exhibit higher expression levels within uterus cells, and these susceptibility genes displayed elevated expression levels in leukocytes, mature NK T cells, and T cells in the uterus. CONCLUSIONS: Our integrated multi-omics analysis identified genetic variants influencing spontaneous abortion risk and their downstream molecular mechanisms, providing insights into potential therapeutic targets. The implicated pathways and cell types may guide future investigations into the pathogenesis of spontaneous abortion.
Disease module: DeepOracle (Open Targets). Structures: RDKit from PubChem SMILES. Literature: retrieved by DeepSearch across 234,678,978 indexed works (targeted per-candidate search), resolved on OpenAlex.
DeCure is a research and publication project, not medical advice and not a treatment. "DeCure for X" describes a research goal, not a claim that a cure exists. Backing a cure is a contribution to fund the research — it is not an investment, and confers no yield, royalty, equity or IP ownership. Papers are published open-access by the DeCure.ai DAO.
